Longwood Capital Partners »

Third Harmonic Bio shares owned by Longwood Capital Partners

Quarter-by-quarter ownership of Third Harmonic Bio (THRD) shares owned by Longwood Capital Partners from 13F filings

Historical chart of Longwood Capital Partners investment in Third Harmonic Bio

Tip: Access up to 7 years of quarterly data

All positions including Third Harmonic Bio held by Longwood Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Third Harmonic Bio by Longwood Capital Partners

Quarter filed Position value Share count Share price at filing
2024-12-31 $512k 50k 10.29
2024-09-30 $210k 16k 13.55

More positions owned by Longwood Capital Partners

Ocular Therapeutix (OCUL)
Cidara Therapeutics Com New (CDTX)
Tourmaline Bio (TRML)
Aadi Bioscience (WHWK)
Insmed Com Par $.01 (INSM)
Bright Minds Biosciences Com New (DRUG)
Argen Se - Sponsored Adr (ARGX)
Amylyx Pharmaceuticals (AMLX)
Terns Pharmaceuticals (TERN)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Compass Therapeutics (CMPX)
Praxis Precision Medicines I (PRAX)
Surrozen Com New (SRZN)
Ascendis Pha- Sponsored Adr (ASND)
Krystal Biotech (KRYS)

View all positions for Longwood Capital Partners

Top funds holding Third Harmonic Bio

BML Capital Management
Morgan Stanley
JBF Capital
Dimensional Fund Advisors
Cantor Fitzgerald, L. P.
Nuveen
Rhumbline Advisers
MetLife Investment Advisors
NISA Investment Advisors
Meeder Asset Management
Summit Investment Advisors
Caldwell Sutter Capital
Russell Investments
Amalgamated Bank
GAMMA Investing

View all funds holding Third Harmonic Bio